Trial Profile
A randomized, double-blind, placebo controlled trial evaluating the safety and efficacy of etanercept 25mg twice weekly in subjects with moderate to severe persistent asthma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 13 Oct 2020
Price :
$35
*
At a glance
- Drugs Etanercept (Primary)
- Indications Asthma
- Focus Therapeutic Use
- Sponsors Wyeth
- 29 May 2007 Status changed from in progress to completed.
- 26 Nov 2005 New trial record.